NAFLD Fibrosis Score

Non-alcoholic fatty liver disease assessment.

Medical Disclaimer

This tool is for educational and screening purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Fibrosis Biomarkers

Age (Years)

Platelets (10³/µL)

AST (U/L)

ALT (U/L)

FIB-4 Index

1.35

LOW RISK FOR ADVANCED FIBROSIS

APRI Score

0.38

Found this tool helpful? Share it with your friends!

About NAFLD Fibrosis Score

The NAFLD Fibrosis Score is a validated, non-invasive diagnostic tool designed to assess the likelihood of advanced liver fibrosis in patients with Non-alcoholic Fatty Liver Disease (NAFLD). This score is invaluable for clinicians and healthcare professionals managing individuals at risk for liver disease progression. By utilizing readily available clinical and laboratory parameters, including age, BMI, hyperglycemia, platelet count, albumin, and AST/ALT ratio, it provides a quantitative risk stratification. Its primary value lies in its ability to help identify patients who may benefit from more intensive follow-up or referral for further specialized evaluation, such as liver biopsy, thereby optimizing patient care pathways and reducing unnecessary invasive procedures.